Have a personal or library account? Click to login
Postoperative radiotherapy for patients with completely resected pathological stage IIIA-N2 non-small cell lung cancer: a preferential benefit for squamous cell carcinoma Cover

Postoperative radiotherapy for patients with completely resected pathological stage IIIA-N2 non-small cell lung cancer: a preferential benefit for squamous cell carcinoma

Radiology and Oncology
Volume 55 (2021): Issue 1 (March 2021)
By: Cuimeng Tian,  Guimei Liu,  Yongxiang Xu,  Guangrong Xia,  Tongmei Zhang,  Jiaqiang Huang,  Hui Jiang,  Ji Ming Wang and  Baolan Li  
Open Access
|Dec 2020
DOI: https://doi.org/10.2478/raon-2020-0070 | Journal eISSN: 1581-3207 | Journal ISSN: 1318-2099
Journal RSS Feed
Language: English
Page range: 66 - 76
Submitted on: Jul 21, 2020
|
Accepted on: Oct 6, 2020
|
Published on: Dec 3, 2020
Published by: Association of Radiology and Oncology
In partnership with: Paradigm Publishing Services
Publication frequency: 4 issues per year
Keywords:
lung squamous cell carcinoma,
lung adenocarcinoma,
pIIIA-N2,
postoperative radiotherapy
Related subjects:
Medicine,
Clinical medicine,
Internal medicine,
Haematology, oncology,
Radiology

© 2020 Cuimeng Tian, Guimei Liu, Yongxiang Xu, Guangrong Xia, Tongmei Zhang, Jiaqiang Huang, Hui Jiang, Ji Ming Wang, Baolan Li, published by Association of Radiology and Oncology
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 3.0 License.

Previous articleVolume 55 (2021): Issue 1 (March 2021)Next article